C. Westacott and M. Sharif, Cytokines in osteoarthritis: Mediators or markers of joint destruction?, Seminars in Arthritis and Rheumatism, vol.25, issue.4, pp.254-272, 1996.
DOI : 10.1016/S0049-0172(96)80036-9

E. Hedbom and H. Hauselmann, Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation, Cellular and Molecular Life Sciences (CMLS), vol.59, issue.1, pp.45-53, 2002.
DOI : 10.1007/s00018-002-8404-z

M. Honorati, M. Bovara, L. Cattini, A. Piacentini, and A. Facchini, Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis, Osteoarthritis and Cartilage, vol.10, issue.10, pp.799-8070829, 2002.
DOI : 10.1053/joca.2002.0829

M. Hussein, N. Fathi, and A. El-din, Alterations of the CD4+, CD8+ T Cell Subsets, Interleukins-1??, IL-10, IL-17, Tumor Necrosis Factor-?? and Soluble Intercellular Adhesion Molecule-1 in Rheumatoid Arthritis and Osteoarthritis: Preliminary Observations, Pathology & Oncology Research, vol.20, issue.5, pp.321-328, 2008.
DOI : 10.1007/s12253-008-9016-1

J. Bondeson, S. Wainwright, S. Lauder, N. Amos, and C. Hughes, The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inXammatory responses in osteoarthritis, Arthritis Res Ther, vol.8, pp.10-1186, 2006.

I. Chikanza and L. Fernandes, Novel strategies for the treatment of osteoarthritis, Expert Opinion on Investigational Drugs, vol.43, issue.7, pp.1499-1510, 2000.
DOI : 10.1073/pnas.90.22.10764

F. Iannone and G. Lapadula, The pathophysiology of osteoarthritis, Aging Clinical and Experimental Research, vol.28, issue.5, pp.364-372, 2003.
DOI : 10.1007/BF03327357

H. Abbas, A. W. Nicklas, and B. , InXammatory markers and physical function among older adults with knee osteoarthritis, J Rheumatol, vol.31, pp.2027-2031, 2004.

K. Vuolteenaho, T. Moilanen, R. Knowles, and E. Moilanen, The role of nitric oxide in osteoarthritis, Scandinavian Journal of Rheumatology, vol.48, issue.1, pp.247-258, 2007.
DOI : 10.1016/j.pain.2005.10.028

S. Kaneko, T. Satoh, and J. Chiba, Interleukin???6 and interleukin???8 levels in serum and synovial fluid of patients with osteoarthritis, Cytokines, Cellular & Molecular Therapy, vol.6, issue.2, pp.71-7910, 1080.
DOI : 10.1080/13684730050515796

F. Doss, J. Menard, and M. Hauschild, Elevated IL???6 levels in the synovial fluid of osteoarthritis patients stem from plasma cells, Scandinavian Journal of Rheumatology, vol.52, issue.2, pp.136-139, 2007.
DOI : 10.1080/03009740701250785

A. De-hooge, . Van-de, F. Loo, O. Arntz, . Van-den et al., Involvement of IL-6, Apart from Its Role in Immunity, in Mediating a Chronic Response during Experimental Arthritis, The American Journal of Pathology, vol.157, issue.6, pp.2081-2091, 2000.
DOI : 10.1016/S0002-9440(10)64846-8

E. Gravallese and S. Goldring, Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis, AID-ANR1>3.0.CO, pp.2143-2151, 2000.

H. Takayanagi, K. Ogasawara, and S. Hida, T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma, Nature, vol.408, pp.600-605, 2000.

T. Crotti, M. Smith, and H. Weedon, Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis, Annals of the Rheumatic Diseases, vol.61, issue.12, pp.1047-1054, 2002.
DOI : 10.1136/ard.61.12.1047

M. Skoumal, G. Kolarz, and G. Haberhauer, Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis, Rheumatology International, vol.46, issue.7, pp.63-69, 2005.
DOI : 10.1007/s00296-004-0579-1

D. Logar, R. Komadina, and J. Prezelj, Expression of bone resorption genes in osteoarthritis and in osteoporosis, Journal of Bone and Mineral Metabolism, vol.67, issue.4, pp.219-225, 2007.
DOI : 10.1007/s00774-007-0753-0

L. Boiardi, P. Macchioni, and R. Meliconi, Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate, Clin Exp Rheumatol, vol.17, pp.419-425, 1999.

J. Stanczyk, M. Kowalski, and J. Grzegorczyk, RANTES and chemotactic activity in synovial Xuids from patients with rheumatoid arthritis and osteoarthritis, Mediators InXamm, pp.343-348, 2005.

N. Alaaeddine, T. Olee, S. Hashimoto, L. Creighton-achermann, and M. Lotz, Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation, 7<1633::AID- ART286>3.0.CO, pp.1633-1643, 2001.
DOI : 10.1002/1529-0131(200107)44:7<1633::AID-ART286>3.0.CO;2-Z

A. Rammes, J. Roth, and M. Goebeler, Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulindependent pathway, J Biol Chem, vol.272, pp.9496-9502, 1997.

J. Roth, T. Vogl, C. Sorg, and C. Sunderkotter, Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules, Trends in Immunology, vol.24, issue.4, pp.155-15810, 2003.
DOI : 10.1016/S1471-4906(03)00062-0

B. Wipke and P. Allen, Essential Role of Neutrophils in the Initiation and Progression of a Murine Model of Rheumatoid Arthritis, The Journal of Immunology, vol.167, issue.3, pp.1601-1608, 2001.
DOI : 10.4049/jimmunol.167.3.1601

W. Chatham, R. Swaim, H. Frohsin, and . Jr, Degradation of human articular cartilage by neutrophils in synovial fluid, Arthritis & Rheumatism, vol.32, issue.1, pp.51-58, 1993.
DOI : 10.1002/art.1780360109

F. Arnett, S. Edworthy, and D. Bloch, The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis & Rheumatism, vol.143, issue.3, pp.315-324, 1988.
DOI : 10.1002/art.1780310302

M. Goldring, The Role of Cytokines as Inflammatory Mediators in Osteoarthritis: Lessons from Animal Models, Connective Tissue Research, vol.158, issue.1, pp.1-11, 1999.
DOI : 10.1016/S1063-4584(97)80007-6

A. Pilichou, I. Papassotiriou, and K. Michalakakou, High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-??B ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis, Clinical Biochemistry, vol.41, issue.9, pp.746-749, 2008.
DOI : 10.1016/j.clinbiochem.2008.02.011

G. Yuan, K. Masuko-hongo, and M. Sakata, The role of C- C chemokines and their receptors in osteoarthritis, AID-ANR186>3.0.CO, pp.1056-10705, 2001.

P. Youssef, J. Roth, and M. Frosch, Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane, J Rheumatol, vol.26, pp.2523-2528, 1999.

M. Frosch, A. Strey, and T. Vogl, Myeloid-related proteins 8 and 14 are speciWcally secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis, 3<628::AID-ANR20>3.0.CO, pp.628-637, 2000.

J. Brun, R. Jonsson, and H. Haga, Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inXammatory rheumatic diseases, J Rheumatol, vol.21, pp.733-738, 1994.

D. Kane, J. Roth, and M. Frosch, Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis, Arthritis & Rheumatism, vol.160, issue.6, pp.1676-1685, 2003.
DOI : 10.1002/art.10988

D. Viemann, A. Strey, and A. Janning, Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells, Blood, vol.105, issue.7, pp.2955-2962, 2004.
DOI : 10.1182/blood-2004-07-2520

S. Drynda, B. Ringel, and M. Kekow, Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNF?? therapy, Pathology - Research and Practice, vol.200, issue.2, pp.165-171, 2004.
DOI : 10.1016/j.prp.2004.02.011

D. Haynes, T. Crotti, and M. Loric, Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint, Rheumatology, vol.40, issue.6, pp.623-630, 2001.
DOI : 10.1093/rheumatology/40.6.623

D. Tanaka, T. Kagari, H. Doi, and T. Shimozato, Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis, Immunology, vol.135, issue.2, pp.195-202, 2006.
DOI : 10.1083/jcb.105.6.2959